Free Access
Issue |
Med Sci (Paris)
Volume 28, Number 6-7, Juin–Juillet 2012
|
|
---|---|---|
Page(s) | 646 - 651 | |
Section | M/S Revues | |
DOI | https://doi.org/10.1051/medsci/2012286019 | |
Published online | 16 July 2012 |
- Chatenoud L, Salomon B, Bluestone JA. Suppressor T cells: they’re back and critical for regulation of autoimmunity! Immunol Rev 2001 ; 182 : 149–163. [CrossRef] [PubMed] [Google Scholar]
- Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010 ; 10 : 490–500. [CrossRef] [PubMed] [Google Scholar]
- Aschenbrenner K, D’Cruz LM, Vollmann EH, et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007 ; 8 : 351–358. [CrossRef] [PubMed] [Google Scholar]
- Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996 ; 184 : 387–396. [CrossRef] [PubMed] [Google Scholar]
- Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 ; 155 : 1151–1164. [PubMed] [Google Scholar]
- Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 ; 299 : 1057–1061. [CrossRef] [PubMed] [Google Scholar]
- Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011 ; 11 : 119–130. [CrossRef] [PubMed] [Google Scholar]
- Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006 ; 203 : 1701–1711. [CrossRef] [PubMed] [Google Scholar]
- Miyara M, Yoshioka Y, Kitoh A, et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009 ; 30 : 899–911. [CrossRef] [PubMed] [Google Scholar]
- Tran DQ, Andersson J, Wang R, et al. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009 ; 106 : 13445–13450. [CrossRef] [Google Scholar]
- Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007 ; 8 : 191–197. [CrossRef] [PubMed] [Google Scholar]
- Malek TR, Yu A, Vincek V, et al. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002 ; 17 : 167–178. [CrossRef] [PubMed] [Google Scholar]
- Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010 ; 10 : 849–859. [CrossRef] [PubMed] [Google Scholar]
- Darrasse-Jeze G, Bergot AS, Durgeau A, et al. Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J Clin Invest 2009 ; 119 : 2648–2662. [PubMed] [Google Scholar]
- Maury S, Lemoine FM, Hicheri Y, et al. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation. Sci Transl Med 2010 ; 2 : 41ra52. [CrossRef] [PubMed] [Google Scholar]
- Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer 2010 ; 127 : 759–767. [PubMed] [Google Scholar]
- Boros P, Bromberg JS. Human FOXP3+ regulatory T cells in transplantation. Am J Transplant 2009 ; 9 : 1719–1724. [CrossRef] [PubMed] [Google Scholar]
- Cohen JL, Trenado A, Vasey D, et al. CD4+CD25+ immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002 ; 196 : 401–406. [CrossRef] [PubMed] [Google Scholar]
- Mittrucker HW, Kaufmann SH. Mini-review: regulatory T cells and infection: suppression revisited. Eur J Immunol 2004 ; 34 : 306–312. [CrossRef] [PubMed] [Google Scholar]
- Palomares O, Yaman G, Azkur AK, et al. Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010 ; 40 : 1232–1240. [CrossRef] [PubMed] [Google Scholar]
- Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007 ; 450 : 566–569. [CrossRef] [PubMed] [Google Scholar]
- Choi BM, Pae HO, Jeong YR, et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005 ; 327 : 1066–1071. [CrossRef] [PubMed] [Google Scholar]
- Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007 ; 204 : 1257–1265. [CrossRef] [PubMed] [Google Scholar]
- Bopp T, Becker C, Klein M, et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007 ; 204 : 1303–1310. [CrossRef] [PubMed] [Google Scholar]
- Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 2001 ; 167 : 1137–1140. [PubMed] [Google Scholar]
- Grossman WJ, Verbsky JW, Barchet W, et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 ; 21 : 589–601. [CrossRef] [PubMed] [Google Scholar]
- Grinberg-Bleyer Y, Baeyens A, You S, et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 2010 ; 207 : 1871–1878. [CrossRef] [PubMed] [Google Scholar]
- Roncarolo MG, Gregori S, Battaglia M, et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006 ; 212 : 28–50. [CrossRef] [PubMed] [Google Scholar]
- Levings MK, Roncarolo MG. Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory T cells. Curr Top Microbiol Immunol 2005 ; 293 : 303–326. [CrossRef] [PubMed] [Google Scholar]
- Wu K, Bi Y, Sun K, Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 2007 ; 4 : 269–275. [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.